Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 27;28(151):180096.
doi: 10.1183/16000617.0096-2018. Print 2019 Mar 31.

Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review

Affiliations

Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review

Syed H Haider et al. Eur Respir Rev. .

Abstract

Background: Our group has identified the receptor for advanced glycation end-products (RAGE) as a predictor of World Trade Center particulate matter associated lung injury. The aim of this systematic review is to assess the relationship between RAGE and obstructive airways disease secondary to environmental exposure.

Methods: A comprehensive search using PubMed and Embase was performed on January 5, 2018 utilising keywords focusing on environmental exposure, obstructive airways disease and RAGE and was registered with PROSPERO (CRD42018093834). We included original human research studies in English, focusing on pulmonary end-points associated with RAGE and environmental exposure.

Results: A total of 213 studies were identified by the initial search. After removing the duplicates and applying inclusion and exclusion criteria, we screened the titles and abstracts of 61 studies. Finally, 19 full-text articles were included. The exposures discussed in these articles include particulate matter (n=2) and cigarette smoke (n=17).

Conclusion: RAGE is a mediator of inflammation associated end-organ dysfunction such as obstructive airways disease. Soluble RAGE, a decoy receptor, may have a protective effect in some pulmonary processes. Overall, RAGE is biologically relevant in environmental exposure associated lung disease. Future investigations should focus on further understanding the role and therapeutic potential of RAGE in particulate matter exposure associated lung disease.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: S.H. Haider has nothing to disclose. Conflict of interest: A. Oskuei has nothing to disclose. Conflict of interest: G. Crowley has nothing to disclose. Conflict of interest: S. Kwon has nothing to disclose. Conflict of interest: R. Lam has nothing to disclose. Conflict of interest: J. Riggs has nothing to disclose. Conflict of interest: M. Mikhail has nothing to disclose. Conflict of interest: A. Talusan has nothing to disclose. Conflict of interest: A. Veerappan has nothing to disclose. Conflict of interest: J.S. Kim has nothing to disclose. Conflict of interest: E.J. Caraher has nothing to disclose. Conflict of interest: A. Nolan has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Flow diagram as per PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [40]. OAD: obstructive airways disease; AGER: advanced glycation end-product receptor.

Similar articles

Cited by

References

    1. Ling SH, van Eeden SF. Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009; 4: 233–243. - PMC - PubMed
    1. Dockery DW, Pope CA, Xu X, et al. . An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993; 329: 1753–1759. - PubMed
    1. Schwartz J. Short term fluctuations in air pollution and hospital admissions of the elderly for respiratory disease. Thorax 1995; 50: 531–538. - PMC - PubMed
    1. Wu L, Ma L, Nicholson LF, et al. . Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. Respir Med 2011; 105: 329–336. - PubMed
    1. Penyige A, Poliska S, Csanky E, et al. . Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study. BMC Med Genet 2010; 11: 152. - PMC - PubMed

Publication types

MeSH terms